| Product Code: ETC9971446 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the United States saw a significant decline in the import shipments of next-generation biomanufacturing products, with a CAGR of -31.87% from 2020 to 2024. Despite the decrease, top exporting countries such as Austria, Metropolitan France, Italy, Germany, and Brazil continued to contribute to the market. The Herfindahl-Hirschman Index (HHI) indicated very low market concentration, reflecting a diverse import landscape. The negative growth rate of -39.06% from 2023 to 2024 suggests ongoing challenges in the biomanufacturing sector, prompting a closer examination of factors influencing this downward trend.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Next Generation Biomanufacturing Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Next Generation Biomanufacturing Market Revenues & Volume, 2022 & 2032F |
3.3 United States (US) Next Generation Biomanufacturing Market - Industry Life Cycle |
3.4 United States (US) Next Generation Biomanufacturing Market - Porter's Five Forces |
3.5 United States (US) Next Generation Biomanufacturing Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 United States (US) Next Generation Biomanufacturing Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 United States (US) Next Generation Biomanufacturing Market Revenues & Volume Share, By End-User, 2022 & 2032F |
4 United States (US) Next Generation Biomanufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for biopharmaceuticals and biotechnology products |
4.2.2 Technological advancements in biomanufacturing processes |
4.2.3 Growing focus on personalized medicine and precision therapies |
4.3 Market Restraints |
4.3.1 High capital investment required for setting up next-generation biomanufacturing facilities |
4.3.2 Regulatory challenges and compliance requirements |
4.3.3 Limited skilled workforce in the field of biomanufacturing |
5 United States (US) Next Generation Biomanufacturing Market Trends |
6 United States (US) Next Generation Biomanufacturing Market, By Types |
6.1 United States (US) Next Generation Biomanufacturing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Next Generation Biomanufacturing Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 United States (US) Next Generation Biomanufacturing Market Revenues & Volume, By Continuous Upstream Biomanufacturing, 2022 - 2032F |
6.1.4 United States (US) Next Generation Biomanufacturing Market Revenues & Volume, By Single-Use Upstream Biomanufacturing, 2022 - 2032F |
6.1.5 United States (US) Next Generation Biomanufacturing Market Revenues & Volume, By Downstream Biomanufacturing, 2022 - 2032F |
6.2 United States (US) Next Generation Biomanufacturing Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Next Generation Biomanufacturing Market Revenues & Volume, By Monoclonal Antibodies, 2022 - 2032F |
6.2.3 United States (US) Next Generation Biomanufacturing Market Revenues & Volume, By Hormones, 2022 - 2032F |
6.2.4 United States (US) Next Generation Biomanufacturing Market Revenues & Volume, By Vaccines, 2022 - 2032F |
6.2.5 United States (US) Next Generation Biomanufacturing Market Revenues & Volume, By Recombinant Proteins, 2022 - 2032F |
6.2.6 United States (US) Next Generation Biomanufacturing Market Revenues & Volume, By Others, 2022 - 2032F |
6.3 United States (US) Next Generation Biomanufacturing Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Next Generation Biomanufacturing Market Revenues & Volume, By Biopharmaceutical Companies, 2022 - 2032F |
6.3.3 United States (US) Next Generation Biomanufacturing Market Revenues & Volume, By Research Institutions, 2022 - 2032F |
6.3.4 United States (US) Next Generation Biomanufacturing Market Revenues & Volume, By CMOs/CDMOs, 2022 - 2032F |
7 United States (US) Next Generation Biomanufacturing Market Import-Export Trade Statistics |
7.1 United States (US) Next Generation Biomanufacturing Market Export to Major Countries |
7.2 United States (US) Next Generation Biomanufacturing Market Imports from Major Countries |
8 United States (US) Next Generation Biomanufacturing Market Key Performance Indicators |
8.1 Percentage of biopharmaceuticals in the total pharmaceutical market |
8.2 Number of patents filed for next-generation biomanufacturing technologies |
8.3 Investment in research and development for biomanufacturing processes |
8.4 Adoption rate of automation and digitalization in biomanufacturing facilities |
9 United States (US) Next Generation Biomanufacturing Market - Opportunity Assessment |
9.1 United States (US) Next Generation Biomanufacturing Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 United States (US) Next Generation Biomanufacturing Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 United States (US) Next Generation Biomanufacturing Market Opportunity Assessment, By End-User, 2022 & 2032F |
10 United States (US) Next Generation Biomanufacturing Market - Competitive Landscape |
10.1 United States (US) Next Generation Biomanufacturing Market Revenue Share, By Companies, 2025 |
10.2 United States (US) Next Generation Biomanufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here